SECsense Logo

DiaMedica Therapeutics Inc. 8-K Filing: Key Financial Insights & Updates

$DMAC
Form 8-K
Filed on: 2025-02-24
Source
DiaMedica Therapeutics Inc. 8-K Filing: Key Financial Insights & Updates

Here are the key insights extracted from the provided financial report section:

  1. Filing Type: The document is an 8-K filing, which typically indicates that the company is reporting significant events that shareholders should know about.
  2. Company Information:
  • Name: DiaMedica Therapeutics Inc.
  • CIK (Central Index Key): 0001401040
  • SEC File Number: 001-36291
  • Address: 301 Carlson Parkway, Suite 210, Minneapolis, MN 55305
  • Telephone: 763-496-5454
  1. Stock Information:
  • Trading Symbol: DMAC
  • Exchange: NASDAQ
  • Type of Shares: Voting common shares
  1. Report Date: The report covers a specific date, which is February 20, 2025.
  2. Context ID: The context ID for this report is "d20258K", which can be used to reference this specific filing in databases.
  3. XML and XBRL Compliance: The report is structured in XBRL format, which is used for standardizing the reporting of financial data. This suggests that the information is machine-readable and can be analyzed more efficiently.

Overall, this section of the financial report provides basic identification details of DiaMedica Therapeutics Inc., indicates a significant filing with the SEC, and conforms to modern digital reporting standards. Further analysis would require details about the specific events or disclosures made in this 8-K filing.